Navigation Links
Vestaron Corporation Announces New Leadership
Date:4/28/2011

KALAMAZOO, Mich., April 28, 2011 /PRNewswire/ -- Vestaron Corporation, a Kalamazoo-based company developing the next- generation of environmentally conscious insecticide products, announced today that John Sorenson, Ph.D., will serve as interim President and Chief Executive Officer. The Board of Directors thanks John McIntyre for his years of service leading to the development of breakthrough insecticides for agriculture.

"John's scientific leadership has been just what Vestaron needed to get us to where we are today," said Jim Schultz of Open Prairie Ventures, a major investor and board director. "We wish John well in his next endeavor."

John Sorenson, Ph.D., will serve as interim President and CEO and continue his current role as Chairman of the Board of Directors. Elin Miller will continue her role as Vice Chairman while the company searches for a new CEO. Vestaron has engaged Kincannon & Reed for the search, which has already begun.

"This is a critical and exciting time for our company with upcoming field trials this summer, which will set the stage for our registration submission. I am thrilled to take the helm," said Dr. Sorenson. Dr. Sorenson has a broad background in plant biotechnology, both in academe and in the private sector. In addition to serving as President of Biotechnology for Syngenta, he also served as President of Syngenta Seed, Inc. and held several positions in the Asgrow Seed Company. Sorenson began his career as Assistant and Associate Professor of Genetics at North Carolina State University.

Vestaron Corporation is a Kalamazoo, Mich.-based company that has been working for the past few years to develop insecticide products that are harmless to humans and other mammals and are environmentally conscious. Using the polypeptides found in spider venom, Vestaron which was formerly known as Venomix, Inc., has reported that its tests are seeing positive results against mosquitoes, caterpillars, flies and cockroaches.

Vestaron Corporation is a portfolio company of Open Prairie Ventures, an Effingham, Illinois- based venture capital firm with offices in Kalamazoo and Southwest Michigan First Life Science Fund.


'/>"/>
SOURCE Vestaron Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mitsubishi Chemical Corporation Signs Memorandum of Understanding for Strategic Partnership With Genomatica for Sustainable Chemicals in Asia
2. Every Day is Earth Day for Yulex Corporation
3. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
4. CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation
5. delSECUR CORPORATION Announces Its Dissolution; and the Distribution of Its Asset to Its Lenders and Shareholders of the Corporation
6. Techne Corporation Announces Acquisition
7. Ther-Rx Corporation Commits to Take Action Regarding Makena™ Pricing
8. SARcode Corporation to Present Phase 2 Clinical Data for Dry Eye Candidate at the ARVO2011 Annual Meeting
9. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
10. Volcano Corporation Presentation at Roth Capital Conference to be Webcast
11. Sanford Rose Associates® - Minneapolis Fills Key Management Position for the Micromedics Operation of Nordson Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 20, 2017 Ginkgo Bioworks, the organism ... pioneer in the synthesis and assembly of DNA. ... assembling pathway-length synthetic DNA into Ginkgo,s automated organism ... the construction of new organism designs for application ... "Gen9 was founded to significantly increase the world,s ...
(Date:1/19/2017)... HOUSTON , Jan. 19, 2017 ... formation of its Medical/Clinical Advisory Board.  This new ... who enhance the range and depth of expertise ... its novel prenatal diagnostic tests.  These experts are ... guidance for the company,s product development and commercialization ...
(Date:1/19/2017)... GAITHERSBURG, Md. , Jan. 19, ... Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious ... agreement for the merger of PharmAthene and Altimmune ... Novartis Venture Fund, HealthCap, Truffle Capital and Redmont ... and diversified immunotherapeutics company with four clinical stage ...
(Date:1/19/2017)... , ... January 19, 2017 , ... FireflySci Inc. is ... rate. The tremendous growth is accounted to two main factors. The first ... the expanding network of vendors supplying FireflySci products all around the world. , 2016 ...
Breaking Biology Technology:
(Date:12/22/2016)... -- SuperCom (NASDAQ:   SPCB ... Public Safety, HealthCare, and Finance sectors announced today that Leaders in ... implement and deploy a community-based supportive services program to reduce recidivism ... further expanding its presence in the state. ... This new program, which is expected to ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):